Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pauling (cayman) Ltd Svf currently holds 21,904,963 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pauling (cayman) Ltd Svf has been a net seller of RLAY stock. They have purchased $0 and sold $116.4M worth of shares.
Pauling (cayman) Ltd Svf's most recent insider trade was on Aug 25, 2026, when they sold 6,000,000 shares at $19.40 per share.
Pauling (cayman) Ltd Svf serves as Executive at Relay Therapeutics, Inc. (RLAY). They have executed 2 insider transactions totaling $116.4M over their tenure at the company.
Pauling (cayman) Ltd Svf holds the position of Executive at Relay Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Pauling (cayman) Ltd Svf has shown a selling trading pattern, with $0 in total purchases and $116.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pauling (cayman) Ltd Svf was on Aug 25, 2026, when they sold $116.4M worth of RLAY shares. This transaction involved 6,000,000 shares at $19.40 per share.
Pauling (cayman) Ltd Svf currently owns 21,904,963 shares of Relay Therapeutics, Inc. (RLAY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pauling (cayman) Ltd Svf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pauling (cayman) Ltd Svf has 2 Form 4 filings on record as an insider at Relay Therapeutics, Inc..
Set alerts for Pauling (cayman) Ltd Svf and 40,000+ other insiders.